EUVIMEDSkopri EUVIMED
Open access · CC BY-NC-ND 4.0

Impact of parameter settings on the estimation of drug exposure with the individualized dispensing patterns method

Laëtitia Gosselin iD, Clara Lévy, Noémie Sève, Thierry Blanchon, Marianne Sarazin, Louise Rossignol, Maryse Lapeyre-Mestre, Nathanaël Lapidus, Olivier Steichen iD

British Journal of Clinical Pharmacology · 2026

DOI: 10.1002/bcp.70701 ↗

At a glance

Journal article in British Journal of Clinical Pharmacology, 2026. Written by Laëtitia Gosselin and 8 co-authors. Institution: Institut Pierre Louis d'épidémiologie et de Santé publique (IPLESP), Sorbonne Université, INSERM, Paris, France. Major MEDLINE topics: Tramadol, Practice Patterns, Physicians', Rivaroxaban, Analgesics, Opioid. 27 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: French National Agency for Medicines and Health Products Safety, French Health Insurance.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Aim

To assess the impact of parameter settings when using the individualized dispensing patterns (IDP) method to estimate exposure duration from dispensing data.

Methods

We conducted a cohort study using a 2% representative sample of the French healthcare insurance database from 2013 to 2022. The IDP method derives drug exposure distribution in a population sample, applies a selected percentile of this distribution to each individual's initial dispensing and then adjusts subsequent exposures at the individual level, incorporating a possible grace period to link consecutive dispensings into continuous exposure episodes. We studied two drugs with contrasting prescribing patterns: tramadol and rivaroxaban. We varied four parameters independently, compared median episode duration estimates and assessed consistency of exposed days estimates using kappa coefficients.

Results

With the original IDP parameters, median continuous exposure episodes were 47 days for tramadol and 79 days for rivaroxaban. The impact of parameter choice was drug‐specific: Percentile selection affected both drugs (kappa 0.58–0.65 for tramadol; 0.89–0.93 for rivaroxaban), sample population definition affected tramadol only (kappa 0.76), and grace period affected rivaroxaban (kappa 0.74–0.87). Heterogeneity across individual‐level kappa values was always high ( I 2 > 80%). These results informed the selection of drug‐specific parameters, yielding clinically more plausible median episode durations: 15 days for tramadol and 96 days for rivaroxaban.

Conclusion

Consumption patterns in the study population should guide percentile and grace period selection. Tailored accordingly, the IDP method provides an adaptable framework for estimating drug exposure from databases. Transparent reporting of parameter selection is essential to ensure reproducibility and interpretability.

Subjects

MeSH terms (MEDLINE)

TramadolPractice Patterns, Physicians'RivaroxabanAnalgesics, OpioidDrug PrescriptionsHumansFranceDatabases, FactualCohort StudiesFemaleMaleMiddle AgedAgedAdult

Author keywords

cohort studiesdrug utilizationfactor Xa inhibitorshealthcare administrative claimsopioid analgesicspharmacoepidemiology

Substances

TramadolRivaroxabanAnalgesics, Opioid

Authors and institutions

  • Institut Pierre Louis d'épidémiologie et de Santé publique (IPLESP), Sorbonne Université, INSERM, Paris, France.
  • Département de Médecine Générale, Université Paris Cité, Paris, France.
  • Service de Pharmacologie médicale et clinique, CIC 1436, INSERM, Université de Toulouse, Centre Hospitalo-Universitaire de Toulouse (CHU Toulouse), Toulouse, France.
  • Hôpital Tenon, Service de Médecine Interne, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France.

ORCID profiles: Laëtitia Gosselin, Olivier Steichen

Funding

  • French National Agency for Medicines and Health Products Safety
  • French Health Insurance

Cite

APA

Gosselin, L., Lévy, C., Sève, N., Blanchon, T., Sarazin, M., Rossignol, L., Lapeyre-Mestre, M., Lapidus, N., & Steichen, O. (2026). Impact of parameter settings on the estimation of drug exposure with the individualized dispensing patterns method. British Journal of Clinical Pharmacology. https://doi.org/10.1002/bcp.70701

Vancouver

Gosselin L, Lévy C, Sève N, Blanchon T, Sarazin M, Rossignol L, et al. Impact of parameter settings on the estimation of drug exposure with the individualized dispensing patterns method. British Journal of Clinical Pharmacology. 2026. doi:10.1002/bcp.70701

BibTeX
@article{Gosselin2026,
  author = {Gosselin, Laëtitia and Lévy, Clara and Sève, Noémie and Blanchon, Thierry and Sarazin, Marianne and Rossignol, Louise and Lapeyre-Mestre, Maryse and Lapidus, Nathanaël and Steichen, Olivier},
  title = {Impact of parameter settings on the estimation of drug exposure with the individualized dispensing patterns method},
  journal = {British Journal of Clinical Pharmacology},
  year = {2026},
  doi = {10.1002/bcp.70701}
}
Start for free →